RAPT Therapeutics Inc (RAPT)
4.135
-0.11
(-2.59%)
USD |
NASDAQ |
May 16, 16:00
4.135
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Shareholders Equity (Quarterly): 130.84M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 130.84M |
| December 31, 2023 | 147.04M |
| September 30, 2023 | 172.80M |
| June 30, 2023 | 199.68M |
| March 31, 2023 | 220.47M |
| December 31, 2022 | 245.17M |
| September 30, 2022 | 189.31M |
| June 30, 2022 | 202.13M |
| March 31, 2022 | 167.84M |
| December 31, 2021 | 186.38M |
| September 30, 2021 | 201.87M |
| Date | Value |
|---|---|
| June 30, 2021 | 217.58M |
| March 31, 2021 | 91.64M |
| December 31, 2020 | 104.18M |
| September 30, 2020 | 110.05M |
| June 30, 2020 | 122.61M |
| March 31, 2020 | 131.93M |
| December 31, 2019 | 73.12M |
| September 30, 2019 | -124.80M |
| June 30, 2019 | 60.01M |
| March 31, 2019 | -105.75M |
| December 31, 2018 | -97.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-124.80M
Minimum
Sep 2019
245.17M
Maximum
Dec 2022
142.49M
Average
157.44M
Median
Shareholders Equity (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 663.90M |
| Avinger Inc | -6.202M |
| Tonix Pharmaceuticals Holding Corp | 105.52M |
| Skye Bioscience Inc | 78.88M |
| Axsome Therapeutics Inc | 144.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 155.82M |
| Total Liabilities (Quarterly) | 24.98M |